Sign in
QUCY Stock Price, Chart, Stats & News
Mainz Biomed N.V.
Save
18.40M
Market cap
–
Current P/E
–
Forward P/E
QUCY chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 64.31% |
Operating margin | -2091.23% |
Pretax margin | -2421.80% |
Net margin | -2421.80% |
Effective tax rate | – |
ROA | -163.55% |
ROE | -465.82% |
D/E | 0.54x |
Interest coverage ratio | -17.39x |
QUCY valuation
P/E | – |
P/S | 6.16x |
P/B | 0.07x |
P/CF | -0.02x |
P/FCF | -0.32x |
P/OCF | -0.02x |
PEG | -0.00x |
EV multiple | -0.43x |
About
Mainz Biomed N. V. is a specialized enterprise in the field of molecular genetics, primarily focused on cancer diagnostics. The company's core mission involves developing and producing market-ready molecular genetic diagnostic solutions specifically engineered for life-threatening medical conditions.
Similar securities
Based on sector and market capitalization
Report issue